查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715467

非处方药市场按产品类型、疾病/病症类型、配方类型和分销管道划分－2025-2030 年全球预测

Over-The-Counter Consumer Health Products Market by Type, Disease/Disorder Type, Formulation Type, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计非处方药市场规模将在 2024 年成长至 2,205.2 亿美元，2025 年将成长至 2,351.6 亿美元，复合年增长率为 6.78%，到 2030 年将达到 3,270 亿美元。

主要市场统计数据
基准年2024年 2205.2亿美元
预计2025年 2351.6亿美元
预测年份 2030 3270亿美元
复合年增长率（%） 6.78%

过去几年，非处方消费保健品产业经历了显着的成长和转型。在产品开发创新、消费行为变化和自我护理意识不断增强的推动下，这个市场已经发展成为医疗保健生态系统中充满活力且不可或缺的一部分。对方便、有效和可获得的健康解决方案的需求正在推动一种环境，消费者正在积极寻求不仅能解决症状而且能促进整体健康的产品。在这个快速发展的环境中，市场相关人员被迫适应重新定义健康优先事项的新趋势，提供传统选择的复杂版本以及新颖的配方和分销模式。

本介绍深入探讨了当今影响市场的各种因素。它强调并具体化了关键驱动因素，包括产品开发中的技术整合、加强消费者教育以及数位管道在影响购买决策方面日益增强的作用。随着法律规范的调整和技术创新的蓬勃发展，成药市场将从渐进式改进和根本性创新中受益。以下部分将深入探讨影响产业的变革性变化，并透过细分、区域和公司分析提供见解，最终使决策者能够清晰全面地了解市场的当前和未来状况。

改变非处方药市场

在过去的十年中，OTC消费者保健产业经历了变革时期，重新定义了传统的市场动态。科技发展打破了传统的产品开发週期，实现了快速原型製作和个人化的健康解决方案。随着消费者透过数位管道获取更多信息，他们的需求和期望也在不断发展，迫使製造商整合循证实践和创新产品配方。

经济压力以及公众意识的不断增强，正在推动市场转向预防性护理而非被动治疗。这种转变明显体现在旨在早期疗育的产品的激增，强化了保持健康是一个持续的过程，而不是一次性解决的概念。随着竞争加剧，各公司纷纷投资研发，以创造出不仅能立即见效而且有助于长期维持健康的配方。

法规环境正在跟上这些变化，简化非处方药产品的核准流程，以促进更高的品质标准和更快的市场进入。永续性在製造过程中的融入进一步支持了这一变化，使製造商能够吸引有良知的消费者群体。这些变革力量的结合正在创造一个竞争激烈、创新的市场，该市场能够很好地应对日益注重健康的消费者所面临的挑战。

OTC消费者健康领域的关键细分洞察

深入研究市场区隔可以揭示影响非处方药健康领域消费者行为和偏好的复杂因素。该分析从多个维度对市场进行细分，提供了消费者参与度的详细视图。一种细分观点是按产品类型，检视消毒剂、非处方药、个人护理、化妆品、维生素和补充剂等市场。在非处方笺药中，我们透过检视痤疮药物、感冒和过敏药物以及止痛药等子类别进一步区分。这种方法不仅突显了消费者需求，而且还针对特定的健康需求制定了差异化的产品创新策略。

另一个细分视角是疾病或病症的类型。在这里，市场被细分为过敏管理、心血管疾病、慢性疼痛、糖尿病管理、心理健康和保健、骨质疏鬆症等领域。心理健康和保健类别更仔细地研究了助眠剂和缓解压力的药物，突显了优先考虑整体健康的显着趋势。为了使事情变得更加复杂，按配方类型进行细分可以深入了解凝胶和溶液、贴片和经皮系统、粉末以及锭剂和胶囊的偏好。此分析反映了产品供应模式如何影响消费者选择和整体品牌忠诚度。

最后，分销通路也是细分的重要因素。透过观察医院和诊所、大卖场和超级市场以及零售药局等管道，我们可以了解可及性和便利性在产品成功中发挥的关键作用。了解这些多层次的细分可以让相关人员调整他们的策略，微调产品供应以满足不同消费群组的细微需求，同时优化市场覆盖范围。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 快速整合数位健康工具和进阶分析，以增强产品个人化和参与度
      • 消费者越来越偏好透过自我治疗和预防性健康解决方案来管理日常健康问题
    • 限制因素
      • 在需求增加和当地市场波动的情况下确保高效率的供应链运作
    • 机会
      • 增加创新非处方药配方及给药系统研发的投资
      • 健康意识和永续性趋势正在推动消费者对天然和植物来源药产品的兴趣日益浓厚
    • 任务
      • 复杂的监管环境和冗长的核准流程阻碍了市场扩张
  • 市场区隔分析
    • 类型：由于文明病的增加，对止痛药的需求增加
    • 分销管道：即时且专业的医疗保健建议正在推动消费者对医院和诊所的偏好
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 OTC药品市场（依类型）

  • 消毒剂
  • 非处方药
    • 痤疮治疗
    • 感冒和过敏药物
    • 止痛药
  • 个人护理和化妆品
  • 维生素和补充剂

7. 非处方药市场（依疾病/病症类型）

  • 过敏管理
  • 心血管健康
  • 慢性疼痛
  • 糖尿病管理
  • 心理健康与保健
    • 助眠剂
    • 缓解压力
  • 骨质疏鬆症

第八章 OTC药品市场（依处方类型）

  • 凝胶和液体
  • 贴片和经皮
  • 粉末
  • 锭剂和胶囊

第九章非处方药市场（依分销管道）

  • 医院和诊所
  • 大卖场和超级市场
  • 零售药局

第十章美洲非处方药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太非处方药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12.欧洲、中东和非洲OTC药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 3M Company
  • Abbott Laboratories
  • Amway Corporation
  • Archer Daniels Midland Company
  • B. Braun SE
  • Bayer AG
  • Beiersdorf AG
  • Boehringer Ingelheim GmbH
  • Cardinal Health, Inc.
  • Cipla Limited
  • Cosmetic Skin Solutions, LLC
  • Dr. Reddy's Laboratories
  • Essity AB
  • Estee Lauder Companies Inc.
  • FastFill Pack, Inc.
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • InSpec Solutions, LLC
  • Integra Lifesciences Corporation
  • Johnson & Johnson services, Inc.
  • Koninklijke DSM NV
  • L'Oreal SE
  • Lonza Group Ltd.
  • Medline Industries, Inc.
  • Mineral Mine
  • Molnlycke Health Care AB
  • Nardo's Natural, Inc. by by Barbara Corcoran
  • Natures Formulae Ltd.
  • Nestle SA
  • Nichiban Co., Ltd.
  • Onoxa LLC
  • Paul Hartmann AG
  • Pfizer, Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser LLC
  • Sanofi SA
  • Smith & Nephew PLC
  • Sun Pharmaceuticals Ltd.
Product Code: MRR-036C5CF3B4E6

The Over-The-Counter Consumer Health Products Market was valued at USD 220.52 billion in 2024 and is projected to grow to USD 235.16 billion in 2025, with a CAGR of 6.78%, reaching USD 327.00 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 220.52 billion
Estimated Year [2025] USD 235.16 billion
Forecast Year [2030] USD 327.00 billion
CAGR (%) 6.78%

The over-the-counter consumer health sector has witnessed notable growth and transformation over the past few years. Driven by innovations in product development, shifting consumer behavior, and increasing awareness of self-care practices, this market has evolved into a dynamic and integral part of the healthcare ecosystem. The demand for convenient, effective, and accessible health solutions has spurred an environment where consumers actively seek products that not only address symptoms but also promote overall wellness. In this rapidly evolving landscape, market players are compelled to adapt to emerging trends that redefine health priorities, offering a refined mix of traditional options alongside novel formulations and distribution models.

This introduction sets the stage for an in-depth exploration into the various components influencing the market today. It provides context by highlighting key drivers such as technological integration in product development, enhanced consumer education, and the increasing role of digital channels in influencing purchase decisions. As regulatory frameworks adapt and innovation proliferates, the OTC health market is poised to benefit from both incremental improvements and radical innovations. The following sections will delve into the transformative shifts reshaping the industry, offer granular segmentation insights, and provide regional and corporate analyses, ultimately equipping decision-makers with a clear and comprehensive view of the current and future state of the market.

Transformative Shifts in the Consumer Health Landscape

Throughout the past decade, the OTC consumer health sector has undergone transformative shifts that have redefined traditional market dynamics. Advancements in technology have disrupted conventional product development cycles, enabling rapid prototyping and personalized health solutions. As consumers become more informed through digital channels, their needs and expectations are continually evolving, driving manufacturers to integrate evidence-based practices with innovative product formulations.

Economic pressures along with heightened public awareness have led to a market emphasis on preventive care rather than reactive treatment. This change is evident in the surge of products designed for early intervention, reinforcing the idea that health maintenance is a continuous process rather than a one-time fix. As competition intensifies, companies are investing in research and development to create formulations that not only offer immediate relief but also contribute to long term wellness.

Regulatory environments have also kept pace with these changes by streamlining approval processes for OTC products, thereby promoting higher quality standards and faster market entry. The integration of sustainability in production processes further supports this shift, enabling manufacturers to appeal to a conscientious consumer base. Collectively, these transformative forces are setting the stage for a competitive, innovative marketplace that is agile enough to meet the challenges of an ever-demanding health-conscious public.

Key Segmentation Insights in OTC Consumer Health

A deep dive into market segmentation uncovers the intricacies that define consumer behavior and preference in the OTC health arena. The analysis categorizes the market on several dimensions that offer a granular view of consumer engagement. One perspective on segmentation focuses on product type, where the market is studied across disinfectants, non-prescription drugs, personal care and cosmetics, as well as vitamins and supplements. Within non-prescription drugs, further differentiation is achieved by examining sub-categories such as acne therapies, cold and allergy remedies, and pain relievers. This approach not only highlights consumer demand but also differentiates product innovation strategies tailored to specific health needs.

Another lens for segmentation is disease or disorder type. Here, the market is dissected into areas such as allergy management, cardiovascular health, chronic pain, diabetes management, mental health and wellness, and osteoporosis. The mental health and wellness category, which is further explored through sleep aids and stress relief, underscores a significant trend towards prioritizing holistic well-being. Adding to the complexity, segmentation by formulation type offers insights into preferences among gels and liquids, patches and transdermal systems, powders, and tablets and capsules. This analysis reflects how the mode of product delivery can influence consumer choices and overall brand loyalty.

Finally, the distribution channel remains a critical facet of segmentation. By examining channels such as hospitals and clinics, hypermarkets and supermarkets, and retail pharmacies, one can understand how accessibility and convenience play crucial roles in product success. Understanding this layered segmentation enables stakeholders to calibrate their strategies, ensuring that product offerings are finely tuned to meet the nuanced demands of diverse consumer groups while optimizing market reach.

Based on Type, market is studied across Disinfectants, Non-prescription Drugs, Personal Care & Cosmetics, and Vitamin & Supplements. The Non-prescription Drugs is further studied across Acne Therapies, Cold & Allergy Remedies, and Pain Relievers.

Based on Disease/Disorder Type, market is studied across Allergy Management, Cardiovascular Health, Chronic Pain, Diabetes Management, Mental Health and Wellness, and Osteoporosis. The Mental Health and Wellness is further studied across Sleep Aids and Stress Relief.

Based on Formulation Type, market is studied across Gels & Liquids, Patch & Transdermal, Powders, and Tablets & Capsules.

Based on Distribution Channel, market is studied across Hospital & Clinics, Hypermarkets & Supermarkets, and Retail Pharmacies.

Key Regional Insights Across Global Markets

Analyzing the regional dimensions of the OTC consumer health market offers invaluable insight into the geographic diversity of opportunities and challenges. In the Americas, market innovation is driven by a well-established healthcare ecosystem that champions preventive care and digital health solutions. Recognizing the mature landscape of this region, companies are investing heavily in technologies that streamline logistics and enhance consumer engagement.

In contrast, the Europe, Middle East & Africa region offers a blend of highly regulated markets and emerging economies where consumer health trends are beginning to take center stage. Here, the regulatory framework is a double-edged sword, balancing strict quality controls with the need for innovation. The integration of digital and traditional healthcare models is gradually redefining market dynamics, encouraging the adoption of holistic health solutions.

The Asia-Pacific region presents a unique story of rapid growth fueled by rising disposable incomes, increased health awareness, and urbanization. As digital penetration grows and consumers become more health literate, companies are leveraging a combination of localized marketing strategies and cutting-edge product offerings to capture significant market share. Overall, these distinct regional narratives collectively underscore the global importance of adaptability and innovation in catering to diverse markets within the OTC consumer health domain.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Leading the OTC Health Market

The competitive landscape within the OTC consumer health market is populated by an array of influential companies, each contributing uniquely to the sector's evolution. Industry leaders such as 3M Company and Abbott Laboratories continue to define standards with their focus on research-led product development and strategic market positioning. Their innovative approaches are complemented by the diversified portfolios of global conglomerates like Amway Corporation and Archer Daniels Midland Company, which bring a blend of traditional practices and modern technology into the fold.

Established pharmaceutical giants including Bayer AG, Boehringer Ingelheim GmbH, and Cardinal Health, Inc. have been pivotal in driving market expansion through their extensive distribution networks and robust product pipelines. Companies like Cipla Limited and Dr. Reddy's Laboratories further push the boundaries of product efficacy while ensuring affordability. Cosmetic Skin Solutions, LLC alongside Estee Lauder Companies Inc. showcase the evolving convergence between health and beauty, strengthening the personal care and cosmetics segment.

Additional market influencers such as FastFill Pack, Inc. and Glanbia PLC fortify the market with streamlined supply chain efficiencies and nutritional expertise, while stalwarts like GlaxoSmithKline PLC and Glenmark Pharmaceuticals Ltd. bolster consumer confidence through consistent quality and innovative health solutions. In this competitive arena, players including InSpec Solutions, LLC and Integra Lifesciences Corporation highlight the importance of niche expertise, which is further affirmed by the robust presence of Johnson & Johnson services, Inc. and Koninklijke DSM N.V. The narrative continues with L'Oreal SE and Lonza Group Ltd., whose strategic collaborations and sustainable practices have redefined modern health consumerism. Industry pioneers including Medline Industries, Inc., Mineral Mine, Molnlycke Health Care AB, Nardo's Natural, Inc. by Barbara Corcoran, Natures Formulae Ltd., Nestle SA, and Nichiban Co., Ltd. persist in their commitment to innovation and quality. This confluence of strategic vision and market expertise is rounded out by firms such as Onoxa LLC, Paul Hartmann AG, Pfizer, Inc., Piramal Enterprises Ltd., Reckitt Benckiser LLC, Sanofi S.A., Smith & Nephew PLC, and Sun Pharmaceuticals Ltd., which collectively create a robust and competitive marketplace rooted in continuous improvement and consumer trust.

The report delves into recent significant developments in the Over-The-Counter Consumer Health Products Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Amway Corporation, Archer Daniels Midland Company, B. Braun SE, Bayer AG, Beiersdorf AG, Boehringer Ingelheim GmbH, Cardinal Health, Inc., Cipla Limited, Cosmetic Skin Solutions, LLC, Dr. Reddy's Laboratories, Essity AB, Estee Lauder Companies Inc., FastFill Pack, Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., InSpec Solutions, LLC, Integra Lifesciences Corporation, Johnson & Johnson services, Inc., Koninklijke DSM N.V., L'Oreal SE, Lonza Group Ltd., Medline Industries, Inc., Mineral Mine, Molnlycke Health Care AB, Nardo's Natural, Inc. by by Barbara Corcoran, Natures Formulae Ltd., Nestle SA, Nichiban Co., Ltd., Onoxa LLC, Paul Hartmann AG, Pfizer, Inc., Piramal Enterprises Ltd., Reckitt Benckiser LLC, Sanofi S.A., Smith & Nephew PLC, and Sun Pharmaceuticals Ltd.. Actionable Recommendations for Industry Leaders

Leaders in the OTC consumer health market should consider a series of actionable strategies to harness the full potential of evolving market dynamics. First, invest in research and development to create innovative products that not only meet current consumer needs but also anticipate future trends, ensuring a competitive edge in an increasingly saturated market. Emphasizing partnerships across technology and digital health platforms can facilitate the development of products that are both advanced in terms of efficacy and accessibly user-friendly.

Market segmentation should be leveraged to tailor product lines that address specific consumer segments. By integrating data from diverse sources, companies can optimize their offerings for enhanced consumer relevance and higher conversion rates. Aligning product development strategies with both traditional channels and emerging e-commerce opportunities can help diversify revenue streams while ensuring widespread market penetration.

It is also essential to adapt to regional nuances by crafting locally resonant marketing strategies, especially in regions with distinct regulatory and cultural landscapes. Collaborating with local distributors and health professionals can provide valuable insights into consumer behavior and regulatory compliance, thereby aiding successful market entry and expansion. Finally, maintaining transparency and robust post-market surveillance systems can build consumer trust and ensure ongoing relevance in a competitive health ecosystem. These recommendations, supported by continuous data analysis and agile operational frameworks, will support sustained growth and market leadership.

Conclusive Summary and Final Thoughts

The OTC consumer health market is characterized by its rapid growth, innovation, and evolving consumer expectations. This comprehensive analysis has explored several dimensions, including transformative industry shifts, detailed segmentation across product types, disease categories, formulations, and distribution channels, as well as key regional and corporate insights that influence market dynamics. Embracing change, understanding consumer trends, and targeting niche segments are critical for success in this competitive landscape.

In conclusion, companies that can navigate the complexities of a transforming marketplace by combining technological advancement with strategic market insights will be best positioned to capture emerging opportunities and drive sustainable growth. A proactive and well-informed approach remains essential in a sector increasingly defined by consumer choice, innovation, and enhanced product efficacy.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid integration of digital health tools and advanced analytics for enhanced product personalization and engagement
      • 5.1.1.2. Rising consumer preference for self-medication and preventive health solutions to manage everyday health issues
    • 5.1.2. Restraints
      • 5.1.2.1. Ensuring efficient supply chain operations amid rising demand and regional market variabilities
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased investment in research and development for innovative OTC formulations and delivery systems
      • 5.1.3.2. Growing consumer interest in natural and plant-based OTC products fueled by wellness awareness and sustainability trends
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory landscape and lengthy approval processes impeding market expansion
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing need for pain relievers due to increasing incidences of lifestyle-related ailments
    • 5.2.2. Distribution Channel: Growing consumer preference for hospitals & clinics due to immediate and professional healthcare advice
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Over-The-Counter Consumer Health Products Market, by Type

  • 6.1. Introduction
  • 6.2. Disinfectants
  • 6.3. Non-prescription Drugs
    • 6.3.1. Acne Therapies
    • 6.3.2. Cold & Allergy Remedies
    • 6.3.3. Pain Relievers
  • 6.4. Personal Care & Cosmetics
  • 6.5. Vitamin & Supplements

7. Over-The-Counter Consumer Health Products Market, by Disease/Disorder Type

  • 7.1. Introduction
  • 7.2. Allergy Management
  • 7.3. Cardiovascular Health
  • 7.4. Chronic Pain
  • 7.5. Diabetes Management
  • 7.6. Mental Health and Wellness
    • 7.6.1. Sleep Aids
    • 7.6.2. Stress Relief
  • 7.7. Osteoporosis

8. Over-The-Counter Consumer Health Products Market, by Formulation Type

  • 8.1. Introduction
  • 8.2. Gels & Liquids
  • 8.3. Patch & Transdermal
  • 8.4. Powders
  • 8.5. Tablets & Capsules

9. Over-The-Counter Consumer Health Products Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital & Clinics
  • 9.3. Hypermarkets & Supermarkets
  • 9.4. Retail Pharmacies

10. Americas Over-The-Counter Consumer Health Products Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Over-The-Counter Consumer Health Products Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Over-The-Counter Consumer Health Products Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Neutrogena partners with dermatologists for skincare innovation
    • 13.3.2. Abhay HealthTech expands OTC reach with MNP healthcare acquisition
    • 13.3.3. Piramal Pharma explores OTC partnerships amidst strategic debt reduction
    • 13.3.4. NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
    • 13.3.5. iNova to buy Mundipharma's consumer healthcare brands for USD 540 million
    • 13.3.6. WellSpring Consumer Healthcare Acquires OTC Skin Care Brands from Bayer
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Amway Corporation
  • 4. Archer Daniels Midland Company
  • 5. B. Braun SE
  • 6. Bayer AG
  • 7. Beiersdorf AG
  • 8. Boehringer Ingelheim GmbH
  • 9. Cardinal Health, Inc.
  • 10. Cipla Limited
  • 11. Cosmetic Skin Solutions, LLC
  • 12. Dr. Reddy's Laboratories
  • 13. Essity AB
  • 14. Estee Lauder Companies Inc.
  • 15. FastFill Pack, Inc.
  • 16. Glanbia PLC
  • 17. GlaxoSmithKline PLC
  • 18. Glenmark Pharmaceuticals Ltd.
  • 19. InSpec Solutions, LLC
  • 20. Integra Lifesciences Corporation
  • 21. Johnson & Johnson services, Inc.
  • 22. Koninklijke DSM N.V.
  • 23. L'Oreal SE
  • 24. Lonza Group Ltd.
  • 25. Medline Industries, Inc.
  • 26. Mineral Mine
  • 27. Molnlycke Health Care AB
  • 28. Nardo's Natural, Inc. by by Barbara Corcoran
  • 29. Natures Formulae Ltd.
  • 30. Nestle SA
  • 31. Nichiban Co., Ltd.
  • 32. Onoxa LLC
  • 33. Paul Hartmann AG
  • 34. Pfizer, Inc.
  • 35. Piramal Enterprises Ltd.
  • 36. Reckitt Benckiser LLC
  • 37. Sanofi S.A.
  • 38. Smith & Nephew PLC
  • 39. Sun Pharmaceuticals Ltd.

LIST OF FIGURES

  • FIGURE 1. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET MULTI-CURRENCY
  • FIGURE 2. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET MULTI-LANGUAGE
  • FIGURE 3. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET RESEARCH PROCESS
  • FIGURE 4. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET DYNAMICS
  • TABLE 7. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ACNE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COLD & ALLERGY REMEDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PAIN RELIEVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PERSONAL CARE & COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY VITAMIN & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STRESS RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GELS & LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PATCH & TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY OVER-THE-COUNTER CONS